These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27930635)

  • 1. Optimal treatment of unresectable stage III non-small cell lung cancer.
    Bradley JD
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):853-855. PubMed ID: 27930635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of unresectable stage III non-small-cell lung carcinomas].
    Van Houtte P
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535
    [No Abstract]   [Full Text] [Related]  

  • 3. Multimodality approach to management of stage III non-small cell lung cancer.
    Scarpaci A; Mitra P; Jarrar D; Masters GA
    Surg Oncol Clin N Am; 2013 Apr; 22(2):319-28. PubMed ID: 23453337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined modality therapy for stage III non-small cell lung cancer.
    Stinchcombe TE; Fried D; Morris DE; Socinski MA
    Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cure- or care-oriented regimen for stage III non-small-cell lung cancer?
    Hotta K; Nagio T; Matsuo K; Kiura K
    J Clin Oncol; 2011 Apr; 29(11):e320. PubMed ID: 21402605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract]   [Full Text] [Related]  

  • 9. New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease.
    Rengan R; Maity AM; Stevenson JP; Hahn SM
    Clin Cancer Res; 2011 Jul; 17(13):4192-9. PubMed ID: 21576083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of stage III non-small lung carcinomas: is there controversy?].
    Mornex F; Girard N
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S20-3. PubMed ID: 17404534
    [No Abstract]   [Full Text] [Related]  

  • 11. [Latest therapeutic strategy for stage IV non-small cell lung cancer].
    Kawate N
    Nihon Rinsho; 2002 May; 60 Suppl 5():490-3. PubMed ID: 12101720
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 13. The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
    De Ruysscher D; Vansteenkiste J; Belderbos J; Decaluwé H; Dingemans AM
    J Thorac Oncol; 2016 Mar; 11(3):284-6. PubMed ID: 26922920
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS; Curran WJ
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal therapy for elderly patients with early stage non-small cell lung cancer.
    Bunn PA
    Am J Respir Crit Care Med; 2010 Feb; 181(3):201-2. PubMed ID: 20093653
    [No Abstract]   [Full Text] [Related]  

  • 19. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].
    Fournel P
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S8-15. PubMed ID: 15211226
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined modality therapy of non-small cell lung cancer.
    Ruckdeschel JC
    Semin Oncol; 1997 Aug; 24(4):429-39. PubMed ID: 9280223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.